{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:32Z","timestamp":1785908672378,"version":"3.56.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Ethos\u2122 platform enables online adaptive radiotherapy (oART) to mitigate inter-fractional anatomical variations. However, the lengthy \u201cscan-to-beam\u201d workflow introduces the risk of intra-fractional motion. This study aimed to investigate the dosimetric and efficiency differences between IMRT and VMAT with varying angular resolutions, providing data to guide the selection of planning strategies in Ethos-based oART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      Fifteen patients with cervical cancer treated on the Ethos platform were retrospectively analyzed. For each patient, five plans were generated: a standard 9-field IMRT plan and four VMAT plans optimized with angular resolutions of 2\u00b0, 3\u00b0, 4\u00b0, and 5\u00b0 (VMAT\n                      <jats:sub>2<\/jats:sub>\n                      -VMAT\n                      <jats:sub>5<\/jats:sub>\n                      ). Dosimetric metrics for Planning Target Volume (PTV) and Organs at Risk (OARs), along with plan generation efficiency (optimization and calculation time), delivery efficiency (beam-on and total delivery time), and deliverability (gamma analysis), were systematically evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All plans met clinical requirements. IMRT demonstrated superior dose homogeneity (HI: 0.07 \u00b1 0.01) compared to all VMAT groups (0.09-0.10,\n                      <jats:italic>P&amp;lt; 0.001<\/jats:italic>\n                      ). For OARs, IMRT provided better sparing of the rectum, bladder, and bone marrow, and reduced the high-dose bowel metric D2cc; however, bowel V\n                      <jats:sub>30<\/jats:sub>\n                      was lower in the VMAT groups, indicating metric-dependent bowel sparing. In terms of efficiency, IMRT required substantially shorter optimization time (122.8 \u00b1 14.6 s) than VMAT (705.9-742.9 s,\n                      <jats:italic>P&amp;lt; 0.001<\/jats:italic>\n                      ). Conversely, VMAT reduced the total delivery time by approximately 50% compared to IMRT (158.1 s vs. 305.3 s,\n                      <jats:italic>P&amp;lt; 0.001<\/jats:italic>\n                      ). Among VMAT plans, finer resolutions (2\u00b0-3\u00b0) offered slight dosimetric advantages over coarser resolutions (4\u00b0-5\u00b0) but required longer calculation times. Gamma passing rates were &amp;gt;98% (3%\/3mm) for all techniques, with IMRT showing marginally higher accuracy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      On the Ethos platform, the IMRT technique offers a favorable balance for cervical cancer oART, combining superior target homogeneity, improved rectum, bladder, and bone marrow sparing, lower bowel D\n                      <jats:sub>2cc<\/jats:sub>\n                      , and rapid plan generation that minimizes the critical scan-to-beam interval. However, bowel V\n                      <jats:sub>30<\/jats:sub>\n                      was lower with VMAT, suggesting that bowel sparing depends on the selected dose-volume metric.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1888330","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:47:50Z","timestamp":1785905270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platform-specific comparison of IMRT and VMAT angular resolution for Ethos-based online adaptive radiotherapy in cervical cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiangyue","family":"Kong","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongsen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Artificial Intelligence Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haonan","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Physics and Technology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.radonc.2022.10.013","article-title":"Late toxicity within a phase III clinical trial of IG-IMRT in cervix cancer (PARCER): Reanalysis with time weighted adverse event reporting (MOSES)","volume":"177","author":"Supriya","year":"2022","journal-title":"Radiotherapy Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-021-01782-5","article-title":"Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient-and treatment-related parameters","volume":"197","author":"Dr\u00f6ge","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.041","article-title":"Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix","volume":"80","author":"Hasselle","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-019-1308-y","article-title":"MR-guidance in clinical reality: Current treatment challenges and future perspectives","volume":"14","author":"Corradini","year":"2019","journal-title":"Radiat Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13014-024-02438-1","article-title":"Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography","volume":"19","author":"Zeng","year":"2024","journal-title":"Radiat Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phro.2020.12.004","article-title":"Clinical implementation of artificial intelligence-driven cone-beam computed tomography-guided online adaptive radiotherapy in the pelvic region","volume":"17","author":"Sibolt","year":"2021","journal-title":"Phys Imaging Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13479","article-title":"Varian ethos online adaptive radiotherapy for prostate cancer: Early results of contouring accuracy, treatment plan quality, and treatment time","volume":"23","author":"Byrne","year":"2022","journal-title":"J Appl Clin Med Phys"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.11.037","article-title":"Dosimetric impact of intrafraction motion in online-adaptive intensity modulated proton therapy for cervical cancer","volume":"109","author":"Berger","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small Jr","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v16.i12.111601","article-title":"Impact evaluation of intra-fractional variation on online adaptive radiotherapy for postoperative cervical and endometrial cancer","volume":"16","author":"Wang","year":"2025","journal-title":"World J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2008.06.013","article-title":"A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy","volume":"89","author":"Cozzi","year":"2008","journal-title":"Radiotherapy Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2025.36.e65","article-title":"The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer patients after surgery","volume":"36","author":"Wang","year":"2025","journal-title":"J Gynecologic Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s178336","article-title":"Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: A meta-analysis","volume":"11","author":"Bai","year":"2018","journal-title":"OncoTargets Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13014-020-01606-3","article-title":"Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: A single-center prospective randomized controlled trial","volume":"15","author":"Huang","year":"2020","journal-title":"Radiat Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.839","article-title":"Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy","volume":"79","author":"Rose","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/16878507.2019.1707400","article-title":"The influence of increment of gantry on VMAT plan quality for cervical cancer","volume":"12","author":"Chen","year":"2019","journal-title":"J Radiat Res Appl Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1017\/s146039692000093x","article-title":"Dosimetric characteristics of VMAT plans with respect to a different increment of gantry angle size for Ca cervix","volume":"21","author":"Natraj","year":"2022","journal-title":"J Radiother Pract"},{"key":"B21","doi-asserted-by":"crossref","first-page":"7-1","DOI":"10.1088\/978-0-7503-6119-4ch7","article-title":"Overview of artificial-intelligence driven adaptive therapy workflow","volume-title":"Artificial Intelligence in Adaptive Radiation Therapy","author":"Shen","year":"2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"110978","DOI":"10.1016\/j.radonc.2025.110978","article-title":"Bladder filling dynamics during online adaptive prostate stereotactic body radiotherapy: Rationale for using an empty bladder workflow for treatment","volume":"209","author":"Byun","year":"2025","journal-title":"Radiotherapy Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.11.010","article-title":"Increasing treatment accuracy for cervical cancer patients using correlations between bladder-filling change and cervix\u2013uterus displacements: Proof of principle","volume":"98","author":"Ahmad","year":"2011","journal-title":"Radiotherapy Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.10.011","article-title":"Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans","volume":"83","author":"Bondar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2000.93.supplement_3.0219","article-title":"A simple scoring ratio to index the conformity of radiosurgical treatment plans","volume":"93","author":"Paddick","year":"2000","journal-title":"J Neurosurg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2217\/iim.11.22","article-title":"Dose prescription, reporting and recording in intensity-modulated radiation therapy: A digest of the ICRU Report 83","volume":"3","author":"Gregoire","year":"2011","journal-title":"Imaging Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1888330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:47:55Z","timestamp":1785905275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1888330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":26,"alternative-id":["10.3389\/fonc.2026.1888330"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1888330","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"1888330"}}